Similar to other anti-folates, MTX exerts its anti-cancer function mainly by inhibiting the dihydrofolate reductase (DHFR), an enzyme involved in the de novo synthesis of the nucleosides required for nucleic acid production. The gene discussed is DHFR; the disease is cancer.